Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04797611 · ClinicalTrials.gov registry record · NA

STEM-Parkinson's Disease

A NA study of Parkinson Disease and Parkinson's Disease and Parkinsonism, sponsored by Scion NeuroStim.

Completed
Registry status
NA
Development phase
188
Enrollment target
20
Study locations

NCT04797611 is a NA study of Parkinson Disease and Parkinson's Disease and Parkinsonism that has completed, run by Scion NeuroStim. The registered enrollment target is 188 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (96% lower). The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04797611, a NA study of Parkinson Disease and Parkinson's Disease and Parkinsonism, has completed, sponsored by Scion NeuroStim.

COMPLETED
Registry status
NA
Development phase
188 participants
Enrollment target
20
Study locations

Study Summary

This is a double-blinded, controlled, and randomized clinical trial (RCT) to establish the safety and efficacy of a non-invasive neuromodulation device for treating symptoms associated with Parkinson's disease.

Conditions Studied

Parkinson Disease Parkinson's Disease and Parkinsonism

Interventions

  • DEVICE TNM Device

Study Locations (20)

Florida

  • Parkinson's Disease and Movement Disorders Center of Boca Raton - Boca Raton
  • Headlands Research Orlando - Orlando
  • USF Parkinson's Disease and Movement Disorders Center - Tampa

Michigan

  • Quest Research - Farmington Hills
  • Mercy Health Saint Mary's - Grand Rapids

Pennsylvania

  • Thomas Jefferson University - Philadelphia
  • University of Pennsylvania - Philadelphia

Texas

  • Texas Movement Disorder Specialist - Georgetown
  • Houston Methodist Neurological Institute - Houston

Arizona

  • Movement Disorder Center of Arizona - Scottsdale

California

  • Cedars-Sinai Medical Center - Los Angeles

Colorado

  • CenExel Rocky Mountain Clinical Research - Englewood

Kansas

  • University of Kansas Medical Center - Parkinson's Disease Center - Kansas City

Trial Details

FieldValue
Enrollment Target 188 participants
Start Date 2022-05-19
Est. Completion 2024-12-06
Phase NA

Sponsor

Scion NeuroStim

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04797611

The ClinicalTrials.gov registry entry for NCT04797611 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (96% lower). The listed sponsor is Scion NeuroStim, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which TNM Device is the first listed.

NCT04797611 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Florida, Michigan, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04797611 about?

NCT04797611 is a clinical study titled "STEM-Parkinson's Disease". This is a double-blinded, controlled, and randomized clinical trial (RCT) to establish the safety and efficacy of a non-invasive neuromodulation device for treating symptoms associated with Parkinson's disease.

What is the current status of trial NCT04797611?

This trial is currently completed. It is a NA study. The enrollment target is 188 participants. The study started on 2022-05-19. Estimated completion is 2024-12-06.

What conditions does trial NCT04797611 study?

This clinical trial studies the following conditions: Parkinson Disease, Parkinson's Disease and Parkinsonism.

What interventions are being tested in trial NCT04797611?

The interventions under investigation include: TNM Device (DEVICE).

Who is sponsoring clinical trial NCT04797611?

This trial is sponsored by Scion NeuroStim, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04797611 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Florida, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson Disease

All registered trials for this condition

Parkinson's Disease and Parkinsonism

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.